Device Dental and Oral Health

Biomaterials

Payments companies reported to CMS as associated with Biomaterials. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$155Kassociated payments (2023-2025)

1,489clinicians with associated payments

4companies reporting

By year

2023 $65.18

2024 $926

2025 $154K

Payments reported as associated with Biomaterials, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Periodontics $61K

Oral and Maxillofacial Surgery $34K

General Practice (Dentist) $22K

Dentist $21K

Prosthodontics $4,031

Oral & Maxillofacial Surgery $3,895

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Biomaterials

These are the largest totals companies reported as associated with Biomaterials. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Robert Levine	Philadelphia, PA	Periodontics	$15,262.77
David Urbanek	Chesterfield, MO	Oral and Maxillofacial Surgery	$7,538.85
Lorenzo Tavelli	Cambridge, MA	Periodontics	$5,046.69
Colin Richman	Atlanta, GA	Periodontics	$3,626.77
Tamir Wardany	San Francisco, CA	General Practice (Dentist)	$2,729.65
Nikolaos Soldatos	Houston, TX	Periodontics	$2,634.55
Samar Shaikh	Nashua, NH	Periodontics	$2,100.53
Shayan Barootchi	Ann Arbor, MI	Periodontics	$1,731.01
Irina Dragan	Boston, MA	Periodontics	$1,262.17
Rachel Schallhorn	San Antonio, TX	Periodontics	$905.09

Prescribed Biomaterials?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.